Symbol="DNLI"
AssetType="Common Stock"
Name="Denali Therapeutics Inc"
Description="Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. The company is headquartered in South San Francisco, California."
CIK="1714899"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="3993052000"
EBITDA="-376710016"
PERatio="None"
PEGRatio="None"
BookValue="7.07"
DividendPerShare="0"
DividendYield="0"
EPS="-2.8"
RevenuePerShareTTM="0.787"
ProfitMargin="0"
OperatingMarginTTM="-3.894"
ReturnOnAssetsTTM="-0.181"
ReturnOnEquityTTM="-0.393"
RevenueTTM="101463000"
GrossProfitTTM="-250269000"
DilutedEPSTTM="-2.8"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.166"
AnalystTargetPrice="58.93"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="35.62"
PriceToBookRatio="4.747"
EVToRevenue="25.36"
EVToEBITDA="-9.23"
Beta="1.31"
num_52WeekHigh="39.43"
num_52WeekLow="21.74"
num_50DayMovingAverage="29.49"
num_200DayMovingAverage="28.49"
SharesOutstanding="136889000"
DividendDate="None"
ExDividendDate="None"
symbol="DNLI"
open="29.11"
high="29.13"
low="28.63"
price="29.03"
volume="441844.00"
latest_trading_day="2023-07-11"
previous_close="29.17"
change="-0.14"
change_percent="-0.4799%"
aroon_positive_momentum_days="39"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="39"
Volume_recent_avg="763906"
Change_recent_avg="-0.01"
Delta_recent_avg="1.16"
Variance_recent_avg="0.58"
Change_ratio_recent_avg="-0.08"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="39"
Aroon_momentum_negative="61"
image_negative_thumbnail_id_1="1158"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0192.jpeg"
image_negative_thumbnail_id_2="1160"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0194.jpeg"
image_neutral_thumbnail_id_1="593"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0006.jpeg"
image_neutral_thumbnail_id_2="584"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0015.jpeg"
image_positive_thumbnail_id_1="669"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0039.jpeg"
image_positive_thumbnail_id_2="693"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0015.jpeg"
image_professor_thumbnail_id_1="1186"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
image_professor_thumbnail_id_2="1173"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
